Additionally, CSF YKL-40 levels may be associated with the progression of the disease as it increased longitudinally in mild cognitive impairment and Alzheimer’s disease patients but not in persons with normal cognitive function [153] (Table 2). Here, CHI3L1 is linked to Cognitive impairment.